載入...
An anaplastic lymphoma kinase (ALK) fusion oncogene positive metastatic sarcomatoid carcinoma of the lung with good response to crizotinib
Primary sarcomatoid carcinoma (SC) of the lung is a rare tumor that accounts for less than 1% of all lung cancers and compared to other non-small cell lung cancers (NSCLC) they appear more aggressive with poorer prognosis and response to treatment. Carcinosarcoma is one of the subtypes of SC. We rep...
Na minha lista:
| 發表在: | AME Case Rep |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6155677/ https://ncbi.nlm.nih.gov/pubmed/30263998 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/acr.2018.01.01 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|